- Investing Ideas
- /
- New Zealand Pharmaceuticals & Biotech Big Green Snowflakes
New Zealand Pharmaceuticals & Biotech Big Green Snowflakes
Results
4
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
4 companies
BLIS Technologies
Market Cap: NZ$19.2m
Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity.
BLT
NZ$0.015
7D
7.1%
1Y
-11.8%
AFT Pharmaceuticals
Market Cap: NZ$283.1m
Engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally.
AFT
NZ$2.70
7D
10.2%
1Y
-11.8%
Rua Bioscience
Market Cap: NZ$5.4m
Engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally.
RUA
NZ$0.024
7D
-11.1%
1Y
-65.2%
Pacific Edge
Market Cap: NZ$101.5m
A cancer diagnostics company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally.
PEB
NZ$0.13
7D
0.8%
1Y
48.8%